Welcome to LookChem.com Sign In|Join Free

CAS

  • or

729613-71-2

Post Buying Request

729613-71-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

729613-71-2 Usage

Class

Carbazole derivatives

Usage

Organic synthesis, precursor for pharmaceuticals and agrochemicals

Usage

Reagent in chemical reactions, building block for complex organic molecule synthesis

Biological activities

Anti-inflammatory, antimalarial, and anticancer properties

Form

Available as a free base

Check Digit Verification of cas no

The CAS Registry Mumber 729613-71-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,9,6,1 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 729613-71:
(8*7)+(7*2)+(6*9)+(5*6)+(4*1)+(3*3)+(2*7)+(1*1)=182
182 % 10 = 2
So 729613-71-2 is a valid CAS Registry Number.

729613-71-2Downstream Products

729613-71-2Relevant articles and documents

FUNCTIONALISED AND SUBSTITUTED CARBAZOLES AS ANTI-CANCER AGENTS

-

Page/Page column 38; 39, (2016/02/26)

The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a disease or disorder, such as a proliferative disease (preferably cancer), using compounds of the invention.

N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors

Barf, Tjeerd,Lehmann, Fredrik,Hammer, Kristin,Haile, Saba,Axen, Eva,Medina, Carmen,Uppenberg, Jonas,Svensson, Stefan,Rondahl, Lena,Lundbaeck, Thomas

scheme or table, p. 1745 - 1748 (2010/02/28)

Small molecule inhibitors of adipocyte fatty-acid binding protein (A-FABP) have gained renewed interest following the recent publication of pharmacologically beneficial effects of such inhibitors. Despite the potential utility of selective A-FABP inhibito

NOVEL INDOLE DERIVATES AS FABP-4 INHIBITORS

-

Page 41, (2010/02/07)

The present invention relates to novel compounds (I) wherein R0, R1, R2, R3, R4, R5, R6, R7, R8, A, B, n, X, and Y are as defined in the description and claims; and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament, which acts on the fatty acid binding protein FABP-4. The present invention relates to novel compounds (I) wherein R0, R1, R2, R3, R4, R5, R6, R7, R8, A, B, n, X, and Y are as defined in the description and claims; and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament, which acts on the fatty acid binding protein FABP-4.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 729613-71-2